U.S. News & World Report's annual rankings of heart hospitals named Cleveland Clinic No. 1, once again, but there were many changes among the other top 25 hospitals. 

Several key trends at the 2023 annual meeting of the Society of Cardiovascular Computed Tomography were outlined by society President Ed Nicol, MD, including AI, reimbursement issue, business management discussions, and a growing interest in cardiac CT leading to record attendance this year.

The first patient was enrolled in a multicenter clinical trial for the TaurusTrio transcatheter aortic valve replacement system, used for aortic regurgitation.

AI to help interpret cardiac CT was shown to reduce exam read times to improve workflow efficiency, and improve patient diagnostics with additional information on soft plaques. Data was presented in three HeartFlow AI technology studies at SCCT 2023.

The FDA sent notice today that Abbott is pulling the Trifecta aortic surgical heart valve off the U.S. market due to the risk of early structural valve deterioration in less than 5 years. 

The FDA approved UltraSight's AI to show ultrasound users how to perform a diagnostic quality cardiac ultrasound exam at the point of care in multiple settings.

Both conditions are fairly common in patients who undergo TAVR. Is this something cardiologists should be keeping in mind? 

There is a risk of the devices sending a reduced amount of energy to the heart during defibrillation. More than 7,000 devices are being recalled due to this issue.

Creating these complex structures with 3D printing alone has never been possible—until now. 

There have been 30 complaints so far about this issue, including 26 injuries and four deaths.